4.6 Article

Optimizing Dosing of Vagus Nerve Stimulation for Stroke Recovery

Journal

TRANSLATIONAL STROKE RESEARCH
Volume 12, Issue 1, Pages 65-71

Publisher

SPRINGER
DOI: 10.1007/s12975-020-00829-6

Keywords

Vagus; Stroke; Dosing; Motor; Stimulation

Funding

  1. National Institute of Health [R01 NS085167, R01 NS094384]

Ask authors/readers for more resources

The study found that moderate-intensity VNS paired with rehabilitation training maximizes recovery of motor function in models of ischemic stroke. VNS at 0.8 mA was beneficial for functional recovery, while VNS at 0.4 mA and 1.6 mA were not sufficient to improve recovery compared to equivalent rehabilitation without VNS.
Vagus nerve stimulation (VNS) paired with rehabilitative training enhances recovery of function in models of stroke and is currently under investigation for use in chronic stroke patients. Dosing is critical in translation of pharmacological therapies, but electrical stimulation therapies often fail to comprehensively explore dosing parameters in preclinical studies. Varying VNS parameters has non-monotonic effects on plasticity in the central nervous system, which may directly impact efficacy for stroke. We sought to optimize stimulation intensity to maximize recovery of motor function in a model of ischemic stroke. The study design was preregistered prior to beginning data collection (DOI: 10.17605/OSF.IO/BMJEK). After training on an automated assessment of forelimb function and receiving an ischemic lesion in motor cortex, rats were separated into groups that received rehabilitative training paired with VNS at distinct stimulation intensities (sham, 0.4 mA, 0.8 mA, or 1.6 mA). Moderate-intensity VNS at 0.8 mA enhanced recovery of function compared with all other groups. Neither 0.4 mA nor 1.6 mA VNS was sufficient to improve functional recovery compared with equivalent rehabilitation without VNS. These results demonstrate that moderate-intensity VNS delivered during rehabilitation improves recovery and defines an optimized intensity paradigm for clinical implementation of VNS therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available